Monday, August 2, 2021

Spain’s PharmaMar says Covid-19 treatment drug shows clinical efficacy in trials – ET HealthWorld

Spain’s PharmaMar said on Wednesday the first trials of its Aplidin drug on hospitalised patients with moderate Covid-19 showed clinical effects and met safety standards.

The results of these first tests allowed the company to secure Spanish regulatory approval to carry out a late-stage trial on patients in a Phase III trial last month.

“The company has decided to share this data, which demonstrates the therapeutic potential of this drug, with the entire scientific and medical communities, along with patients,” PharmaMar said in a statement.

Britain’s medical regulator authorised the trials two months ago after the journal Science published a paper showing the drug had encouraging antiviral results during vitro testing.

Aplidin is a drug developed by PharmaMar originally to treat cancer but has an effect as an antiviral.

Shares of PharmaMar were up 1% to 80.70 euros ($98.75) in early trading.

Follow and connect with us on , Facebook, Linkedin

Source link

Stay Connected


Latest Articles

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...